Exploring The Antibacterial Properties of Vernonia Amygdalina (Bitter Leaf) Extract A Potential Alternative To Conventional Antibiotics
Exploring The Antibacterial Properties of Vernonia Amygdalina (Bitter Leaf) Extract A Potential Alternative To Conventional Antibiotics
https://doi.org/10.59298/NIJBAS/2024/5.1.606711
Page | 60
Exploring the Antibacterial Properties of Vernonia
amygdalina (Bitter Leaf) Extract: A Potential Alternative
to Conventional Antibiotics
David Musyoki
School of Pharmacy, Kampala International University, Uganda
ABSTRACT
As part of the ongoing search for potent and resistance-free antibacterial medicinal plants, this study aimed to
evaluate the antibacterial properties of the plant extract of Vernonia amygdalina, commonly known as bitter leaf.
Standard procedures were used to provide a potential cheap alternative to conventional medication for treating
bacterial infections. The aqueous extract of V. amygdalina leaves was prepared and subjected to phytochemical
screening, which revealed the presence of tannins, phlobatannins, saponins, terpenoids, cardiac glycosides and
alkaloids. The antibacterial activity of the extract was tested against the gram-positive bacterium Staphylococcus
aureus and the gram-negative bacteria Pseudomonas aeruginosa and Escherichia coli using the agar well diffusion
method. The extract showed moderate antibacterial activity, exhibiting 10 mm and 8 mm zones of inhibition
against S. aureus and P. aeruginosa respectively at a concentration of 20 mg/ml. However, it displayed no activity
against E. coli. In comparison, the standard antibiotic gentamicin produced larger zones of inhibition of 33.5 mm,
27 mm, and 23.5 mm against the respective test organisms. The results suggest that V. amygdalina extract had
greater antibacterial activity on the gram-positive S. aureus than on the gram-negative microorganisms tested. The
presence of phytochemicals like tannins, saponins and alkaloids in the extract may contribute to its antibacterial
properties. Further research is warranted to fully elucidate the medicinal potential of V. amygdalina and isolate the
active compounds responsible for the observed antimicrobial effects. Overall, the findings provide a scientific basis
for the traditional use of this plant in treating bacterial infections.
Keywords: Vernonia amygdalina, Antibacterial activity, Phytochemicals, Antimicrobial resistance, Traditional
medicine
INTRODUCTION
The search for novel, effective, and affordable antimicrobial agents has become a global priority as many infectious
disease-causing bacteria are developing resistance to commonly used synthetic antibiotics [1]. This growing
antimicrobial resistance poses a significant public health concern, especially in developing countries where access
to modern medicine is limited. In response to this challenge, researchers are increasingly turning their attention to
exploring natural plant-based sources for alternative antimicrobial therapies. Traditional herbal medicine has a
long history of use in many Asian, Latin American, and African countries, where up to 80% of the population
relies on plant-derived remedies as their primary healthcare [2, 3, 4]. These traditional practices are founded on
empirical observations passed down through generations, suggesting that certain medicinal plants possess
pharmacological properties beneficial for treating various ailments, including infectious diseases. One such plant
that has garnered attention for its potential antimicrobial applications is Vernonia amygdalina, commonly known
as bitter leaf. V. amygdalina is a tropical shrub indigenous to sub-Saharan Africa that has been used extensively in
traditional medicine [5]. Its leaves, roots, and other plant parts are reported to possess a variety of therapeutic
effects, such as antihelminthic, antimalarial, laxative, and fertility-enhancing properties [6, 7, 8]. Furthermore, the
leaves are commonly consumed as a vegetable in many African cuisines after undergoing processing to reduce their
characteristically bitter taste [9]. Interestingly, observations of wild chimpanzees in Tanzania chewing V.
©NIJBAS OPEN ACCESS
Publications 2024 ONLINE ISSN: 2992-5797
PRINT ISSN: 2992-6122
amygdalina leaves to extract the bitter juice and subsequently returning to normal activity have lent support to
the plant's medicinal value [10]. Traditional healers in various parts of Africa also commonly use V. amygdalina
leaf extracts to treat bacterial infections and chronic skin ulcers, even in cases where antibiotic treatments have
failed [11 - 15].
Previous studies have investigated the antibacterial properties of V. amygdalina extracts against various bacterial
strains. Akinpelu [16] found the plant extract to be effective against Bacillus subtilis, Klebsiella pneumoniae,
Pseudomonas aeruginosa, Proteus vulgaris, Shigella dysenteriae, and Staphylococcus aureus, but inactive against
Page | 61
Escherichia coli and Serratia marcescens. Similarly, Ashebir and Ashenafi [17] reported that a 7% V. amygdalina
extract inhibited the growth of B. cereus, S. aureus, and Shigella flexneri, but had no effect on E. coli. Vernonia
amygdalina has also been shown to contain various secondary metabolites, such as tannins, saponins, alkaloids, and
terpenoids, which have been associated with antimicrobial properties in other medicinal plants [6, 16, 17].
However, the exact mechanisms by which V. amygdalina exerts its antimicrobial effects, as well as the specific
bioactive compounds responsible, remain to be fully elucidated. Further investigation is needed to provide a more
comprehensive understanding of the antibacterial potential of this plant and its potential applications in
traditional and modern medicine. The present study aims to build upon the existing evidence by evaluating the
antibacterial activity of aqueous extracts of V. amygdalina leaves against a panel of clinically relevant bacterial
pathogens, including S. aureus, P. aeruginosa, and E. coli. The findings of this research could contribute to the
development of plant-derived antimicrobial agents and provide a scientific basis for the traditional medicinal use
of V. amygdalina.
METHODOLOGY
Study Site
This was an experimental study carried out at Kampala InternationalUniversity-Western Campus Pharmacy
laboratory.
Equipment and Materials
Petri dishes, aqueous leaf extract, electronic weighing balance, Distilled water, Beakers, Measuring cylinder, Pen,
Water bath, Refrigerator, Nutrient agar, McConkey agar, Spatula, Sterile cork borer, Incubator, Hot air oven.
Plant Material Identification
Vernonia amygdalina plant was identified by a botanist (Professor DominicByarugaba) at Kampala International
University-Western campus and avoucher sample was prepared as herbarium.
Preparation of the Extract (aqueous extraction)
Leaves of Vernonia amygdalina was collected around Ishaka. The leaves werethen air dried for 2 weeks, crushed,
and then blended. 12g of the leaves wereweighed and used in extraction. Extraction was done by dissolving the
groundleaves in 100ml of hot water boiled for thirty minutes in a conical flask andthen was soaked for 24 hours. It
was then filtered using filter paper and dried in a water bath to obtain the extract. The extract was weighed to
obtain the weight/weight.
Phytochemical Screening
Tests for the detection of different secondary metabolites were carried out usingaqueous extracts of Vernonia
amygdalinaaccording to standard procedures as described by [18, 19, 20].
i. Flavonoids
To 5mls of the dilute ammonia solution, 0.2g of Vernonia amygdalina aqueousextract was added followed by the
addition of 2ml concentrated sulphuric acid. Observation of a yellow solution that turns colourless was indicative
of flavonoids.
ii. Tannins
0.2g of the extract was dissolved in 5mls of distilled water and heated in a waterbath for fifteen minutes then
filtered. Three drops of 0.1 %ferric chloride wereadded to the filtrate and observed for the presence of a brownish-
green or blue-blackcoloration indicative of tannins.
iii. Saponins
0.2g of the extract was dissolved in 5 ml of distilled water and then heated toa boil. The formation of a layer of
foam indicated the presence of saponins.
©NIJBAS OPEN ACCESS
Publications 2024 ONLINE ISSN: 2992-5797
PRINT ISSN: 2992-6122
iv. Alkaloids (Mayer's test)
0. 5g of the extract was stirred in 1 % aqueous hydrochloric acid in a steambath for five minutes. Two to
three drops of Mayer's reagent were added to theside of the test tube. Turbidity or a white precipitate
with this reagent wastaken as evidence for the presence of alkaloids.
v. Phlobotannins
0.2g of the extract was dissolved in 5 ml of distilled water and filtered. Thefiltrate was boiled with 2 ml of 2% of
aqueous hydrochloric acid solution. Observation of a red precipitate was considered a positive test for
Page | 62
Phlobotannins.
vi. Steroids
0.2g of the extract was mixed with 2 ml of concentrated sulphuric acid andthereafter2 ml of acetic anhydride was
added to the mixture color changed fromviolet to blue or green indicatingthe presence of steroids.
vii. Cardiac glycosides
A drop of ferric chloride solution was added to 2ml of glacial acetic acid. Thissolution was used to treat 0.5g of
the extract. The mixture was then underlaidwith 1 ml of concentrated sulphuric acid. A brown ring at the
interphase wasindicative of a deoxy-sugar characteristic of cardenolidesA. A violet ring mayalso appear below the
brown ring while in the acetic acid layer, a greenish ringmay form gradually throughout the thin layer indicating
the presence ofcardiac glycosides.
viii. Reducing sugars
0.2g of the extract was shaken with 5ml of distilled water and filtered. Thefiltrate was then boiled with 3 drops
of Fehling's solution A&B for two minutes. An orange solution indicated the presence of a reducing sugar.
Plant Extract Disc Preparation
The plant extract disc was prepared from a labline filter by punching with a corkborer of 6mm diameter and the
disc was autoclaved at 121 degrees Celsius for 15minutes. 0.2g of the extract was then diluted with l0mls of
distilled water togive a concentration of 20mg/ ml and this was added to the discs. Thisconcentration was chosen
as it correlated with the concentration of thestandard antibiotic (gentamycin) that was to be used. The plant
extract discwas then dried in an oven and stored in a refrigerator until required for use.
Culturing of the Test Microorganism
The isolates of the microorganism were obtained from the MicrobiologyLaboratory of Kampala International
University-Western campus. The testorganisms used were Staphylococcus aureus, Pseudomonas
aeruginosaandEscherichia coli. Staphylococcus aureus and Pseudomonas aeruginosamicroorganisms were cultured on
Nutrient Agar plates by dissolving 2.8g ofNutrient Agar in l00mls of water while Escherichia coli was cultured
inMcConkey agar. The media was autoclaved at 121 degrees Celsius for 15 mins.9mls of this media was poured in
plates and left to gel. The microorganismswere later sub-cultured to produce young cultures which were used in
theexperiment.
Determination of Antibacterial Activity
i. Agar well diffusion method
This was carried out according to the method described by Opara and Anasa (1993). The growth media Mueller-
Hinton Agar (MHA) was prepared bydiluting 9g of Mueller-Hinton agar in 250 ml of distilled water and
sterilizing byautoclaving. MHA was allowed to cool to 50 degrees Celsius and 5 ml of themolten agar was then
added to the petri dishes. Three wells of about 6.0mmdiameter were aseptically made on each agar plate using a
sterilecork borer. The cultured microorganisms were later inoculated on the Mueller-Hinton Agarby spreading the
microorganisms uniformly across the Petri dishes. Fixedvolumes (20µl) of the plant extract were then introduced
into the wells. Controlwells containing gentamycin were used as a positive control because it is abroad-spectrum
antibiotic and was set up at the center and distilled water wasthen added to the third well as a negative control.
The plates were incubated at5 degrees for 1 hour to ensure the extract and the controls diffused evenly inthe agar
and then were incubated at 37 degrees Celsius for 24 hrs. The relativesusceptibility of the microorganisms to the
plant extract was determined bymeasuring the zones of inhibition and the experiment was done two times
forstaphylococcus aureus and Escherichia coli plates and once for Pseudomonas aureginosa plates and the mean values
were calculated and recorded.
Statistical Analysis of Data
Test for significance in the zone of inhibition was done by determining themean of the zone of inhibition
produced by the bacteria to know theeffectiveness of each plant extract and the susceptibility of the test organism.
©NIJBAS OPEN ACCESS
Publications 2024 ONLINE ISSN: 2992-5797
PRINT ISSN: 2992-6122
Limitations of the Study
The research results were not as expected due to the failure to isolate and sterilizethe active principles due to a
lack of equipment.
Time Limit
The research study took six months beginning from March 2011 to August 2011.
Sources of Chemicals and Reagents
Chemicals and reagents for phytochemical screening and other reagents wereprovided by the School of Pharmacy,
Page | 63
Kampala International University-WesternCampus.
RESULTS
Extraction
After extraction of 12g of leaf extract in l00mls of distilled water, the yield was3.3g of extract. The percentage
yield obtained was 27.5% w /w i.e. 3.3/ 12 x 100.
Table 1: Phytochemical test
(+) refers to the presence of the phytochemical and (-) refers to the absence of the phytochemical.
Table 2: Antimicrobial activity of extracts of Vernonia amygdalina determined by agar well diffusion
method on specific media for each testmicroorganism